Paolo Pinton Lab__Signal Transduction

Home – Lab members – Research – Lab facilities – Publications – Selected Publications — Lab funds – Map – Contacts & Information

CURRICULUM VITAE SONIA MISSIROLI

Date and place of birth: Ravenna (Italy) January 19th 1984 Nationality: italian
Affiliation and official address: Dept. of Medical Sciences, University of Ferrara, Paolo Pinton's Lab, c/o CUBO Via Fossato di Mortara 70, 44121 Ferrara, Italy.
Telephone: +39-0532455809
e-mail: msssno@unife.it

EDUCATION
2006: Biological Sciences Degree  University of Ferrara
2008: Biomolecular and Cellular Sciences Degree summa cum laude University of Ferrara
2008: National Board, University of Ferrara
2016: PhD in Biochemistry, Molecular Biology and Biotechnology (University of Ferrara)

CAREER/EMPLOYMENT
2009-2012: Fellowship (University of Ferrara)
2013-present: Department of Medical Sciences (University of Ferrara)
2013-present: Referent for the Digital Microscopy facility Industrial Research and Technology Transfer Laboratory (LTTA) accredited by Emilia Romagna Region, Ferrara, Italy

AWARDS
2015: Winner of Bando Giovani ricercatori Università di Ferrara FONDI 5x1000
2016: Winner of Bando Giovani ricercatori Università di Ferrara FONDI 5x1000
2017: Winner of Best PhD Thesis related to XXVIII cycle for Phd in Biochemistry, Molecular Biology and Biotechnology

GRANT
Principal Investigator RICERCA FINALIZZATA GIOVANI RICERCATORI 2021-2023

RESEARCH ACTIVITIES

Molecular and cancer biologist with expertise in the field of cancer. She contributed to the discovering of the role of tumorsuppressors PML in the regulation of autophagy and how PML loss promotes cancer development (Missiroli et al, Cell Reports 2016). Dr. Missiroli published 34 articles (Total IF>200 Total citations > 1.600 and h-index 21,Scopus). Beside cancer biology, which is the main focus of her career, she is now currently focused on exploring the effects of tumor suppressors in the host environment in the regulation of inflammation and defining how this could have an impact in the progression of different diseases (Missiroli et al. Cell Death Dis, 2018). She is also oriented in studying NLRP3 inflammasome involvement in cancer and in neurodegenerative disorders.